2024-10-07 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a leading healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services. 

**1. Performance Relative to S&P 500 (VOO):**

* **Cumulative Return:** CVS: -30.2%  VOO: 133.14%
* **Cumulative Return Difference:** -163.34%
* **Relative Divergence:**  2.39 (indicating that CVS has significantly underperformed the S&P 500 over the period). This means CVS's performance is at the 2.39 percentile of its historical performance range relative to the S&P 500. 

**2. Recent Price Movement:**

* **Closing Price:** $64.59
* **5-Day Moving Average:** $62.83
* **20-Day Moving Average:** $59.22
* **60-Day Moving Average:** $58.76
   
   The stock price has been steadily increasing over the past few months, with the 5-day, 20-day, and 60-day moving averages all trending upwards. This suggests a positive short-term trend, but it's still significantly below its historical highs.

**3. Technical Indicators:**

* **RSI:** 75.7  (High RSI, indicating overbought conditions. The stock might be due for a short-term pullback.)
* **PPO:** 1.07 (Positive PPO, indicating a potential for short-term price increase)
* **Delta_Previous_Relative_Divergence:** -4.78 (- sign indicating a recent short-term bearish trend)
* **Expected Return:** 0.0%  (This represents the expected return over the next 5 years relative to the S&P 500) 

**4. Recent Earnings and Outlook:**

| Date  | EPS  | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report (2024-08-07) showed an EPS of 1.83, beating the expected EPS of 1.73. This demonstrates a positive trend in the company's earnings performance. However, it's important to consider the previous quarters where the company underperformed compared to the analysts' expectations. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** According to FINBOLD, analysts have a mixed outlook on CVS, with a "Hold" recommendation. The stock has faced challenges due to pricing pressures in the pharmacy benefit management (PBM) business and a potential for increased competition in the retail pharmacy segment. 
* **Analyst Opinions:** Some analysts believe CVS is positioned for growth in the healthcare sector and could benefit from the increasing need for pharmacy services.
* **Performance Highlights:**  CVS has been actively expanding its healthcare services, including MinuteClinics, which offer convenient access to healthcare. 

**6.  Summary:**

CVS Health Corp has underperformed the S&P 500 significantly, despite recent positive earnings results. While the stock's technical indicators suggest short-term potential for a price increase, it's important to note the high RSI, which signals a potential for a pullback. The company is facing challenges in the PBM market, but it continues to grow its healthcare services. Investors should monitor the company's performance and industry trends closely before making any investment decisions.

**7. Disclaimer:** This report is for informational purposes only and should not be considered as investment advice. It's essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
